Ignore the noise in GLP-1 stocks. Find the best value instead.

(That's a name to remember. Similar to Novo Nordisk's semaglutide and Eli Lilly's tirzepatide, petrelintide mimics a naturally occurring hormone, causing patients to feel full so that they eat ...

Novo Nordisk's semaglutide, which could be the first oral ... "Delivering protein-based medicine like semaglutide in the form of a tablet and producing it on a large scale is a major challenge ...

In the latest research, scientists from Canada tracked nearly 3,000 Americans who used either semaglutide, the active drug in ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

The results showed that both the oral insulin tablet ... in popularity. Novo Nordisk is investing heavily in another oral formulation: its next-generation GLP-1 analogue semaglutide is set for ...

That same day, the company announced it would initiate phase 3a development of oral semaglutide, a GLP-1 analogue formulated as a once-daily tablet for the treatment of type 2 diabetes. Novo Nordisk, ...

Novo Nordisk A/S's CagriSema faces challenges, yet new trials aim to enhance efficacy, rival Eli Lilly in obesity treatments, ...